{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:06:21Z","timestamp":1769202381812,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.gastrohep.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,12,17]],"date-time":"2011-12-17T01:52:49Z","timestamp":1324086769000},"page":"1-7","source":"Crossref","is-referenced-by-count":6,"title":["Gastroprotection in NSAID and low-dose aspirin users: A cross-sectional study in primary care"],"prefix":"10.1016","volume":"35","author":[{"given":"Angel","family":"Lanas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Josep","family":"Plazas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mu\u00f1oz-Tudur\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2011.10.004_bib0005","first-page":"69","article-title":"Prescribimos antiinflamatorios no esteroideos (AINEs) pero\u2026 \u00bfy la protecci\u00f3n g\u00e1strica?","volume":"12","author":"Corredor","year":"2002","journal-title":"Medifam"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1345\/aph.1M346","article-title":"Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature","volume":"44","author":"Ansara","year":"2010","journal-title":"Ann Pharmacoth"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1572-0241.2005.41833.x","article-title":"A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use","volume":"100","author":"Lanas","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ajg.2009.115","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1157\/13051932","article-title":"Recomendaciones de la Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda y de la Sociedad Espa\u00f1ola de Reumatolog\u00eda, Estrategia cl\u00ednica para la prevenci\u00f3n de los efectos adversos sobre el tracto digestivo de los antiinflamatorios no esteroideos","volume":"26","author":"Lanas","year":"2003","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0030","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cgh.2006.04.010","article-title":"Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin","volume":"4","author":"Wilcox","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2007.084772","article-title":"EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT","volume":"68","author":"Zhang","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.gastrohep.2011.10.004_bib0045","first-page":"iii23","article-title":"Underutilization of preventive strategies in patients receiving NSAIDs","volume":"42","author":"Sturkenboom","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2474-7-79","article-title":"Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice","volume":"7","author":"Moore","year":"2006","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5414\/CPP45281","article-title":"Under-utilization of gastroprotective drugs in patients with NSAID-related ulcers","volume":"45","author":"Vonkeman","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0060","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2006.08.016","article-title":"Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications","volume":"4","author":"Goldstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0065","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.3748\/wjg.15.5953","article-title":"Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications","volume":"15","author":"Lanas","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0070","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/ard.2009.123166","article-title":"Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study","volume":"69","author":"Lanas","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.0306-5251.2001.01476.x","article-title":"Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies","volume":"52","author":"Garc\u00eda-Rodr\u00edguez","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gastrohep.2009.09.009","article-title":"Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study","volume":"33","author":"Lanas","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0085","first-page":"507","article-title":"Antiinflamatorios no esteroideos y protecci\u00f3n gastrointestinal: \u00bfprescripci\u00f3n adecuada en atenci\u00f3n primaria?","volume":"18","author":"Burrull","year":"1996","journal-title":"Atenci\u00f3n Primaria"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0090","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1345\/aph.1D068","article-title":"Inadequate prevention of NSAID-induced gastrointestinal events","volume":"38","author":"Herings","year":"2004","journal-title":"Ann Pharmaco Ther"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00228-004-0782-8","article-title":"Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study","volume":"60","author":"Carvajal","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl. 4","key":"10.1016\/j.gastrohep.2011.10.004_bib0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0210-5705(08)76627-5","article-title":"Update on gastrointestinal disorders associated with non-steroidal anti-inflammatory drugs","volume":"31","author":"Lanas","year":"2008","journal-title":"Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.gastrohep.2011.10.004_bib0105","first-page":"A","article-title":"Prescription rates of PPI therapy are high in patients on dual antiplatelet therapy in Spain, regardless of the presence of risk factors","volume":"136","author":"Casado","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0110","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1365-2036.2010.04281.x","article-title":"Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs)","volume":"31","author":"Valkhoff","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2036.2003.01550.x","article-title":"A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole","volume":"17","author":"Labenz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0120","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs","volume":"292","author":"Laheij","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0125","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1542\/peds.2005-1655","article-title":"Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children","volume":"117","author":"Canani","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0130","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.gastrohep.2011.10.004_bib0135","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570511003700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570511003700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T18:51:28Z","timestamp":1543344688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570511003700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0210570511003700"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2011.10.004","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}